COVID‑19 antibody production by vaccination in chemotherapy with CD20 antibody for B‑cell lymphoma.

Mol Clin Oncol · 2023 · PMC10619194 · PMID 37920416

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In the present study, CD19 was considered a key factor associated with the acquisition of an effective antibody titer, with a highly significant difference between anti-S titers of 0.8 and 264 U/ml.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.